Joe Betts-Lacroix
CEO & Founder @ Retro Biosciences
San Francisco Bay Area, United States
Joe Betts-Lacroix is a seed investor at Retro Biosciences in San Francisco Bay Area focused on Life Science and Biotechnology. Joe Betts-Lacroix is the Founder and CEO of Retro. He previously worked at Recursion as an Advisor. Joe Betts-Lacroix attended Harvard University.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Joe Betts-Lacroix invests in
Stages Joe Betts-Lacroix invests in
Countries Joe Betts-Lacroix invests in
Round sizes
Round size
- Seed
- $3.6M–$4.3M
Investment Focus
Industry
- Life Science 2 (100%)
- Biotechnology 2 (100%)
- Pharmaceutical 2 (100%)
- Blockchain 1 (50%)
- Health Care 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
VitaDAO
|
VitaDAO is a decentralized collective funding early stage longevity research Our mission is to extend human lifespan by researching, financing, and commercializing longevity therapeutics in an open and democratic manner.VitaDAO and its members are committed to nurturing and developing the intellectual property, licenses, and data sets that resultfrom the projects it supports.Members can join VitaDAO by purchasing VITA tokens or earning them through contributions of work or Intellectual Property. | $3.6M / Seed / Jan 30, 2023 | |
Spring Discovery
|
Spring Discovery is accelerating the discovery of therapies for aging.By targeting the biological processes of aging itself, we aim to uncover new therapies for the diseases of old age — from cardiovascular to neurodegenerative disease — and increase our healthy lifespans. We've built a machine learning platform to accelerate experimentationfor discovering such therapies.We're hiring! https://www.springdisc.com/#careers | $4.3M / Seed / Feb 26, 2018 |
Co-Investors
About Retro Biosciences
Retro Biosciences focuses on cellular reprogramming, autophagy, and plasma-inspired therapeutics. The company is engaged in cellular reprogramming, autophagy, and developing therapeutics inspired by plasma to combat aging. Retro Biosciences aims to extend healthy human lifespan by 10 years through innovative biotechnology focused on aging.
Retro Biosciences Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Joe Betts-Lacroix
CEO & Founder
|
|||
Kristen Fortney
Advisor
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Joe Betts-Lacroix invest in?
Joe Betts-Lacroix invests primarily in Life Science, Biotechnology and Pharmaceutical startups, most often at Seed stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Joe Betts-Lacroix's check size?
Joe Betts-Lacroix typically joins rounds of $3.6M–$4.3M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Joe Betts-Lacroix participates in.
When did Joe Betts-Lacroix last invest?
The most recent investment recorded for Joe Betts-Lacroix closed in Jan 2023. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
